Two generic AIDS treatments by Indian manufacturer Cipla have been reinstated on the World Health Organisation’s recommended list, six months after they were removed for further testing. WHO officials say that Lamivudine and Duovir, which combines lamivudine with zidovudine in one dose, have been important to the strategy to broaden treatment of HIV/AIDS patients in poor countries, China Radio International reported Wednesday.
